Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Press release

RLS Global AB: ChloraSolv recommended for UK CA certification required for UK market after Brexit

RLS Global

As a result of Brexit, a so-called UK CA certification will be required for medical devices placed on the market in Great Britain. Today, a positive recommendation for UK CA certification has been provided for RLS Global's wound debridement product ChloraSolv.

"RLS Global has now securedalong-term regulatory compliance, and hence, access to the UK market for ChloraSolv", says Roland Frösing, acting CEO, RLS Global.

RLS Global is now awaiting the formal UK CA certificate.

  

THIS IS CHLORASOLV
ChloraSolv is a debriding gel, based on a unique hypochlorite technology, which is used with very good effect on leg ulcers and diabetic foot ulcers. The gel allows the gentle removal of devitalised tissue and promotes natural wound healing.1ChloraSolv does not damage healthy tissue and is well tolerated by the patient.

1. Eliasson, B., Fagerdahl, A.M., Jönsson, A., Apelqvist, J. Debriding effect of amino acid-buffered hypochlorite on hard-to-heal wounds covered by devitalized tissue: pilot study. Journal of Wound Care (June 2021) 30(6):455-464.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.